NewAmsterdam Pharma raises $196m through Series A funding round
Clinical stage company NewAmsterdam Pharma (NAP) has raised $196m (€160m) through Series A funding round...
AM-Pharma enrols first Covid-19 patients in Phase III clinical trial
AM-Pharma has announced the enrolment of first participants in an exploratory cohort in Phase III...
KU Leuven, Batavia partner to develop Covid-19 vaccine candidate
KU Leuven in Belgium has partnered with contract development and manufacturing organisation, Batavia Biosciences, to...
Equflow Sensors
Equflow develops and produces disposable and single-use flowmeters, as well as all required components, for...
Lead Pharma enters oral molecules development deal with Roche
Lead Pharma has signed a collaboration and license agreement with Roche for the development of...
Scenic Biotech forms drug development alliance with Genentech
Scenic Biotech has entered into a multi-year strategic partnership with Roche unit Genentech in a...
Intravacc and Celonic team up to develop Covid-19 vaccine
Intravacc has partnered with contract development and manufacturing organisation (CDMO) Celonic Group for the design,...
Sanofi partners with Kymera in $2bn protein degrader therapies deal
Sanofi has formed a multi-programme collaboration with biotechnology firm Kymera Therapeutics to develop and commercialise...
Intravacc licences CimCure’s iBoost vaccine technology
Dutch research and development vaccine institute Intravacc has collaborated with cancer immunotherapies developer CimCure to...
Intravacc forms alliance to develop intranasal Covid-19 vaccine
Dutch research and development vaccine institute Intravacc has collaborated with Wageningen Bioveterinary Research (WBVR) and...